Hypertension Clinical Trials in London
17 recruitingLondon, United Kingdom
Showing 1–17 of 17 trials
Recruiting
Not Applicable
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
HypertensionHypertension, SystolicHypertension,Essential
Orchestra BioMed, Inc500 enrolled98 locationsNCT06059638
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Prospective Evaluation of AI-ECG for SHD Detection
Heart Failure With Preserved Ejection Fraction (HFpEF; Diagnosis)Valvular Heart Disease Stenosis and Regurgitation (Diagnosis)Pulmonary Hypertension (Diagnosis)+1 more
Imperial College London590 enrolled5 locationsNCT07057466
Recruiting
Phase 2
A Trial of "APL-9796'' in Adults With Pulmonary Hypertension
Pulmonary Arterial Hypertension
Apollo Therapeutics Ltd48 enrolled5 locationsNCT06846554
Recruiting
Phase 2
A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.
Chronic Kidney Disease and Hypertension
AstraZeneca218 enrolled70 locationsNCT07222917
Recruiting
Not Applicable
IIH Intervention: A Clinical Trial Comparing 2 Treatments (Shunts and Stents) Evaluation Of Clinical Effectiveness And Cost Effectiveness
IIH - Idiopathic Intracranial Hypertension
University of Birmingham80 enrolled15 locationsNCT07440277
Recruiting
Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled229 locationsNCT07181109
Recruiting
Phase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
AstraZeneca5,000 enrolled753 locationsNCT06742723
Recruiting
Developing the Probability Algorithm for Pulmonary Hypertension Echocardiography
Pulmonary Hypertension
Royal United Hospitals Bath NHS Foundation Trust2,500 enrolled5 locationsNCT06386185
Recruiting
Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk
HypertensionCardiovascular RiskBlood Pressure Check (Hypertension Screening)
Aktiia SA15,000 enrolled2 locationsNCT06670677
Recruiting
Not Applicable
Real World Evaluation of Lifelight®: A Contactless Vital Signs Monitor for Self-monitoring Blood Pressure and Its Comparison to Standard of Care
Hypertension
Xim Limited500 enrolled1 locationNCT06325384
Recruiting
Quantifying 18kDa TSPO Expression in the Lung in Pulmonary Artery Hypertension (PAH)
HealthyPulmonary Arterial Hypertension
Imperial College London6 enrolled1 locationNCT05745961
Recruiting
Not Applicable
The Man Van Project
Prostate CancerUrologic CancerBladder Cancer+8 more
Royal Marsden NHS Foundation Trust4,000 enrolled1 locationNCT06357416
Recruiting
Not Applicable
Controlling and Lowering Blood Pressure With the MobiusHD™
Hypertension
Vascular Dynamics, Inc.200 enrolled22 locationsNCT02827032
Recruiting
The "Global Paradise System" Registry
Hypertension
ReCor Medical, Inc.3,000 enrolled35 locationsNCT05027685
Recruiting
Phase 4
Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of Oesophageal Varices Trial.
Cirrhosis, LiverPortal HypertensionVariceal Hemorrhage+1 more
King's College Hospital NHS Trust1,200 enrolled1 locationNCT05872698
Recruiting
The European NAFLD Registry
Hepatocellular CarcinomaObesityCardiovascular Diseases+9 more
Newcastle University10,000 enrolled37 locationsNCT04442334